col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


39 Results       Page 1

 [1] 
SPb RAACI: Russian Journal of Infection and Immunity
  original article Date Title Authors   All Authors
1 [GO] 2022―May―12 T HELPER CELL SUBSETS AND THEIR TARGET CELLS IN ACUTE COVID-19 I. Kudryavtsev, A. Golovkin, A. Totolian
2 [GO] 2022―May―12 PATHOMORPHOLOGICAL FEATURES OF ARDS IN COMPETING LUNG DISEASES: COVID-19 AND SARCOIDOSIS О. V. Vorobeva, N. E. Gimaldinova, L. P. Romanova
3 [GO] 2022―May―12 Comparison of the humoral and cellular immunity in COVID-19 convalescents Anna P. Toptygina, Elena L. Semikina, Rustam Sh. Zakirov, Zulfiia E. Afridonova
4 [GO] 2022―May―12 FEATURES OF THE NEW CORONAVIRUS INFECTION COVID-19 IN IDENTICAL TWINS S. Yudina, V. Kiseleva, T. Rusanova, I. Ivanova
5 [GO] 2022―May―12 RESISTANCE FACTORS OF KLEBSIELLA PNEUMONIAE BACTERIA DURING COVID-19 PANDEMIC O. N. Kolotova, L. V. Kataeva, I. V. Bakshtanovskaya, K. B. Stepanova, T. F. Stepanova
6 [GO] 2022―May―12 RHINO- AND RS-VIRUSES IN THE COVID-19 PANDEMIC I. V. Kiseleva, A. D. Ksenafontov
7 [GO] 2022―May―12 EVALUATION OF SERUM LEVELS OF IL-6 AND ADIPONECTIN IN COVID-19 PATIENTS AND THEIR RELATIONSHIP WITH DISEASE SEVERITY M. Norouzian, Khojasteh Sharifi-Sarasiabi, Majid Najafi-Asl, M. Hassani Azad, H. Estabraghnia Babaki
8 [GO] 2022―May―12 Local and systemic adverse reactions following COVID-19 vaccine (clinical report) N. Yu. Zherebtsova, T. V. Kajdanek
9 [GO] 2022―May―12 QUANTITATIVE AND QUALITATIVE COMPOSITION OF LYMPHOCYTE POPULATIONS AND SUBSETS IN PATIENTS WITH VARYING SEVERITY OF A NEW CORONAVIRUS INFECTION I. A. Ivanova, A. A. Trufanova, A. V. Filippenko, N. D. Omelchenko, A. K. Noskov, O. S. Chemisova
10 [GO] 2022―May―12 EVALUATION OF THE TWO IN-PATIENT HOSPITALS ON POTENTIAL ENVIRONMENTAL HAZARD DURING THE PERIOD OF NEW CORONAVIRUS INFECTION IN THE KHABAROVSK CITY (DECEMBER 2020 - MARCH 2021) O. E. Trotsenko, A. P. Bondarenko, N. Y. Pshenichnaya, T. A. Zaitseva, Y. A. Garbuz, I. V. Chishagorova, et al. (+3)
11 [GO] 2022―May―12 Anti-interferon alpha autoantibodies and their significance in COVID-19 S. S. Petrikov, N. V. Borovkova, K. A. Popugaev, Mayya V. Storozheva, A. M. Kvasnikov, M. A. Godkov
12 [GO] 2022―May―12 The third ethical commentary to COVID-19 (two years later) - vaccination, solidarity, and trust O. I. Kubar, G. L. Mikirtichan, E. Yu. Vladimirova, T. G. Taghi-zade, F. M. Mamedova, U. K. Gadgieva, et al. (+8)
13 [GO] 2022―Mar―14 Etiological pattern of community-acquired pneumonia related to the new coronavirus infection COVID-19 pandemic in the Saratov Region S. A. Portenko, E. S. Kazakova, E. V. Naidenova, N. A. Osina, M. V. Proskuriakova, A. D. Katyshev, et al. (+11)
14 [GO] 2022―Mar―14 Revealing measles cases in Vietnam during the spread of a new coronavirus infection I. N. Lavrentieva, M. Hoang, A. Y. Antipova, M. A. Bichurina, A. A. Totolyan
15 [GO] 2022―Mar―14 <i>In vitro</i> antiviral activity of VIFERON® rectal suppositories against SARS-CoV-2 I. N. Isakova-Sivak, E. A. Stepanova, L. G. Rudenko, M. S. Bartov, E. N. Vyzhlova, V. V. Malinovskaya
16 [GO] 2021―Dec―15 Differential and diagnostic significance of monocytosis in treatment of moderate forms of COVID-19 M. Shperling, E. Shperling, A. Kovalev, A. Vlasov, A. Polyakov, Ya. Noskov, et al. (+4)
17 [GO] 2021―Dec―15 Gender-Related Response of Body Systems in COVID-19 Affects Outcome M. Khaksari, N. Sabet, Z. Soltani, H. Bashiri
18 [GO] 2021―Dec―15 INFLUENCE OF ULTRAVIOLET BLOOD IRRADIATION ON COVID-19 ASSOCIATED COMMUNITY-ACQUIRED PNEUMONIA I. Khodza, P. Puzdryak, P Bondarenko, A. Degtyarev, A. Erofeev, K. Chizhova, et al. (+2)
19 [GO] 2021―Dec―15 SALIENT FEATURES OF CIRCULATING RESPIRATORY VIRUSES IN THE PRE- AND PANDEMIC INFLUENZA AND COVID-19 SEASONS I. V. Kiseleva, N. V. Larionova, E. P. Grigorieva, A. D. Ksenafontov, M. Al Farroukh, L. G. Rudenko
20 [GO] 2021―Dec―15 The correlation between RAS and COVID-19, short review of the latest evidence F. Ferrara, A. Vitiello
21 [GO] 2021―Dec―15 IMMUNOGRAPH-BASED ANALYSIS OF THE INFLUENZA A (H1N1)PDM09 VACCINE STRAIN IMMUNOGENICITY IN THE PANDEMIC AND POST-PANDEMIC PERIOD (2009-2014) V. S. Vakin, I. V. Amosova, E. M. Vojcekhovskaya, T. A. Timoshicheva, A. A. Vasileva, M. G. Pozdnyakova, et al. (+4)
22 [GO] 2021―Nov―22 Study of features of humoral immune response to the new coronavirus infection COVID-19 among healthcare workers I. D. Reshetnikova, Yu. A. Tyurin, E. V. Agafonova, S. N. Kulikov, G. F. Gilyazutdinova, D. V. Lopushov, et al. (+3)
23 [GO] 2021―Nov―22 Herd immunity to SARS-CoV-2 among the population of the Republic of Belarus amid the COVID-19 pandemic A. Yu. Popova, A. A. Tarasenko, V. Yu. Smolensky, S. A. Egorova, V. S. Smirnov, A. M. Dashkevich, et al. (+37)
24 [GO] 2021―Sep―21 COVID-19 as a zoonotic infection A. N. Kulichenko, O. V. Maletskaya, N. S. Sarkisyan, A. S. Volynkina
25 [GO] 2021―Sep―21 Methodology for assessing herd immunity to the SARS-CoV-2 virus in the context of the COVID-19 pandemic A. Yu. Popova, A. A. Totolian
26 [GO] 2021―Mar―24 Features of developing SARS-CoV-2 nucleocapsid protein population-based seroprevalence during the first wave of the COVID-19 epidemic in the Russian Federation A. Yu. Popova, E. E. Andreeva, E. A. Babura, S. V. Balakhonov, N. S. Bashketova, M. V. Bulanov, et al. (+27)
27 [GO] 2021―Mar―24 A single blind, placebo-controlled randomized study of the safety, reactogenicity and immunogenicity of the “EpiVacCorona” Vaccine for the prevention of COVID-19, in volunteers aged 18-60 years (phase I-II) A. B. Ryzhikov, Е. А. Ryzhikov, M. P. Bogryantseva, S. V. Usova, E. D. Danilenko, E. A. Nechaeva, et al. (+17)
28 [GO] 2021―Mar―02 Second ethical comments towards COVID-19 (one year later) O. I. Kubar, M. A. Bichurina, N. I. Romanenkova
29 [GO] 2020―Sep―28 Parthenolide: suggested drug for COVID-19 M. Nemati, F. Danesh Pouya, E. Roshani Asl, Y. Rami
30 [GO] 2020―Sep―28 THE COVID-19 PANDEMIC: A SYSTEMATIC REVIEW OF THE CURRENT EVIDENCE R. Ghomi, N. Asgari, A. Hajiheydari, R. Esteki, F. Biyabanaki, F. Nasirinasab
31 [GO] 2020―Aug―08 Organ-specific pathomorphological changes during COVID-19 O. V. Vorobeva, A. V. Lastochkin
32 [GO] 2020―Aug―08 COVID-19 and BCG vaccine: is there a link? I. V. Lyadova, A. A. Starikov
33 [GO] 2020―Aug―08 Lessons to learn: COVID-19 epidemic in Italy A. V. Semenov, N. Y. Pshenichnaya
34 [GO] 2020―Aug―08 COVID-19: etiology, clinical picture, treatment M. Yu. Shchelkanov, L. V. Kolobukhina, O. A. Burgasova, I. S. Kruzhkova, V. V. Maleev
35 [GO] 2020―Aug―08 Some opportunities for immunotherapy in coronavirus infection V. S. Smirnov, Areg A. Totolian
36 [GO] 2020―May―22 An early assessment of the efficacy of medicines in the treatment of patients with COVID-19 A. S. Kolbin
37 [GO] 2020―May―22 COVID-19: an updated review F. A. Isihak, M. A. Hamad, N. G. Mustafa
38 [GO] 2020―Apr―12 INNATE IMMUNITY IN CORONAVIRUS INFECTION V. Smirnov, A. Totolyan
39 [GO] 2020―Apr―12 THE HISTORY OF INVESTIGATION AND MODERN CLASSIFICATION OF CORONAVIRUSES (NIDOVIRALES: CORONAVIRIDAE) M. Yu. Shchelkanov, A. Yu. Popova, V. G. Dedkov, V. G. Akimkin, V. V. Maleyev
 [1] 

39 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.014 sec